Gene-Chemical Interaction Annotations Click to see Annotation Detail View
Object Symbol | Species | Term | Qualifier | Evidence | With | Reference | Notes | Source | Original Reference(s) | Pelo | Rat | (+)-schisandrin B | multiple interactions | EXP | | 6480464 | schizandrin B inhibits the reaction [Carbon Tetrachloride results in increased expression of PELO mRNA] | CTD | PMID:31150632 | Pelo | Rat | (S)-colchicine | decreases expression | ISO | PELO (Homo sapiens) | 6480464 | Colchicine results in decreased expression of PELO mRNA | CTD | PMID:24211769 | Pelo | Rat | 1,2-dimethylhydrazine | multiple interactions | ISO | Pelo (Mus musculus) | 6480464 | [1 and 2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of PELO mRNA | CTD | PMID:22206623 | Pelo | Rat | 17alpha-ethynylestradiol | multiple interactions | ISO | Pelo (Mus musculus) | 6480464 | [Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of PELO mRNA | CTD | PMID:17942748 | Pelo | Rat | 17beta-estradiol | increases expression | ISO | PELO (Homo sapiens) | 6480464 | Estradiol results in increased expression of PELO mRNA | CTD | PMID:20106945 | Pelo | Rat | 17beta-estradiol | multiple interactions | ISO | PELO (Homo sapiens) | 6480464 | [Estradiol co-treated with Norethindrone Acetate] results in increased expression of PELO mRNA and [Estradiol co-treated with Progesterone] results in increased expression of PELO mRNA | CTD | PMID:20660070 and PMID:22217510 | Pelo | Rat | 2,3,7,8-tetrachlorodibenzodioxine | multiple interactions | ISO | Pelo (Mus musculus) | 6480464 | [Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of PELO mRNA | CTD | PMID:17942748 | Pelo | Rat | 2,3,7,8-tetrachlorodibenzodioxine | affects expression | ISO | Pelo (Mus musculus) | 6480464 | Tetrachlorodibenzodioxin affects the expression of PELO mRNA | CTD | PMID:21570461 and PMID:24680724 | Pelo | Rat | 2,4-dinitrotoluene | affects expression | EXP | | 6480464 | 2 and 4-dinitrotoluene affects the expression of PELO mRNA | CTD | PMID:21346803 | Pelo | Rat | acrylamide | increases expression | ISO | PELO (Homo sapiens) | 6480464 | Acrylamide results in increased expression of PELO mRNA | CTD | PMID:32763439 | Pelo | Rat | adenine | decreases expression | ISO | PELO (Homo sapiens) | 6480464 | Adenine results in decreased expression of PELO mRNA | CTD | PMID:24211769 | Pelo | Rat | aflatoxin B1 | increases expression | ISO | PELO (Homo sapiens) | 6480464 | Aflatoxin B1 results in increased expression of PELO mRNA | CTD | PMID:27153756 | Pelo | Rat | aflatoxin B1 | decreases methylation | ISO | PELO (Homo sapiens) | 6480464 | Aflatoxin B1 results in decreased methylation of PELO gene | CTD | PMID:27153756 | Pelo | Rat | all-trans-retinoic acid | increases expression | ISO | PELO (Homo sapiens) | 6480464 | Tretinoin results in increased expression of PELO mRNA | CTD | PMID:17431108 more ... | Pelo | Rat | antirheumatic drug | increases expression | ISO | PELO (Homo sapiens) | 6480464 | Antirheumatic Agents results in increased expression of PELO mRNA | CTD | PMID:24449571 | Pelo | Rat | aristolochic acid A | increases expression | ISO | PELO (Homo sapiens) | 6480464 | aristolochic acid I results in increased expression of PELO mRNA | CTD | PMID:33212167 | Pelo | Rat | arsane | multiple interactions | ISO | Pelo (Mus musculus) | 6480464 | [APOE protein affects the susceptibility to Arsenic] which results in increased expression of PELO mRNA | CTD | PMID:22719926 | Pelo | Rat | arsenic atom | multiple interactions | ISO | Pelo (Mus musculus) | 6480464 | [APOE protein affects the susceptibility to Arsenic] which results in increased expression of PELO mRNA | CTD | PMID:22719926 | Pelo | Rat | benzene | increases expression | ISO | PELO (Homo sapiens) | 6480464 | Benzene results in increased expression of PELO mRNA | CTD | PMID:19162166 | Pelo | Rat | benzo[a]pyrene | decreases expression | ISO | Pelo (Mus musculus) | 6480464 | Benzo(a)pyrene results in decreased expression of PELO mRNA | CTD | PMID:21569818 | Pelo | Rat | benzo[a]pyrene | increases expression | ISO | PELO (Homo sapiens) | 6480464 | Benzo(a)pyrene results in increased expression of PELO mRNA | CTD | PMID:20106945 more ... | Pelo | Rat | benzo[e]pyrene | increases methylation | ISO | PELO (Homo sapiens) | 6480464 | benzo(e)pyrene results in increased methylation of PELO exon | CTD | PMID:30157460 | Pelo | Rat | beta-naphthoflavone | increases expression | ISO | PELO (Homo sapiens) | 6480464 | beta-Naphthoflavone results in increased expression of PELO mRNA | CTD | PMID:19737606 | Pelo | Rat | bis(2-chloroethyl) sulfide | decreases expression | ISO | PELO (Homo sapiens) | 6480464 | Mustard Gas results in decreased expression of PELO mRNA | CTD | PMID:12884408 | Pelo | Rat | bisphenol A | decreases expression | ISO | Pelo (Mus musculus) | 6480464 | bisphenol A results in decreased expression of PELO mRNA | CTD | PMID:26063408 | Pelo | Rat | bisphenol A | decreases expression | EXP | | 6480464 | bisphenol A results in decreased expression of PELO mRNA | CTD | PMID:33296240 | Pelo | Rat | bisphenol A | increases expression | EXP | | 6480464 | bisphenol A results in increased expression of PELO mRNA | CTD | PMID:25181051 more ... | Pelo | Rat | cadmium atom | increases expression | ISO | PELO (Homo sapiens) | 6480464 | Cadmium results in increased expression of PELO mRNA | CTD | PMID:23369406 | Pelo | Rat | cadmium dichloride | increases expression | EXP | | 6480464 | Cadmium Chloride results in increased expression of PELO mRNA | CTD | PMID:19010381 | Pelo | Rat | carbon nanotube | decreases expression | ISO | Pelo (Mus musculus) | 6480464 | Nanotubes and Carbon analog results in decreased expression of PELO mRNA | CTD | PMID:25554681 | Pelo | Rat | chlorpyrifos | increases expression | ISO | Pelo (Mus musculus) | 6480464 | Chlorpyrifos results in increased expression of PELO mRNA | CTD | PMID:37019170 | Pelo | Rat | chromium(6+) | affects expression | ISO | Pelo (Mus musculus) | 6480464 | chromium hexavalent ion affects the expression of PELO mRNA | CTD | PMID:28472532 | Pelo | Rat | cisplatin | decreases expression | ISO | PELO (Homo sapiens) | 6480464 | Cisplatin results in decreased expression of PELO mRNA | CTD | PMID:24211769 | Pelo | Rat | cobalt dichloride | increases expression | ISO | PELO (Homo sapiens) | 6480464 | cobaltous chloride results in increased expression of PELO mRNA | CTD | PMID:19376846 and PMID:20105288 | Pelo | Rat | cobalt dichloride | increases expression | EXP | | 6480464 | cobaltous chloride results in increased expression of PELO mRNA | CTD | PMID:24386269 | Pelo | Rat | copper(II) sulfate | increases expression | ISO | PELO (Homo sapiens) | 6480464 | Copper Sulfate results in increased expression of PELO mRNA | CTD | PMID:19549813 | Pelo | Rat | cyclosporin A | increases expression | ISO | PELO (Homo sapiens) | 6480464 | Cyclosporine results in increased expression of PELO mRNA | CTD | PMID:20106945 more ... | Pelo | Rat | Dibutyl phosphate | affects expression | ISO | PELO (Homo sapiens) | 6480464 | di-n-butylphosphoric acid affects the expression of PELO mRNA | CTD | PMID:37042841 | Pelo | Rat | dibutyl phthalate | increases expression | EXP | | 6480464 | Dibutyl Phthalate results in increased expression of PELO mRNA | CTD | PMID:21266533 | Pelo | Rat | dorsomorphin | multiple interactions | ISO | PELO (Homo sapiens) | 6480464 | [NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1 more ... | CTD | PMID:27188386 | Pelo | Rat | doxorubicin | increases expression | ISO | PELO (Homo sapiens) | 6480464 | Doxorubicin results in increased expression of PELO mRNA | CTD | PMID:29803840 | Pelo | Rat | entinostat | increases expression | ISO | PELO (Homo sapiens) | 6480464 | entinostat results in increased expression of PELO mRNA | CTD | PMID:27188386 | Pelo | Rat | entinostat | multiple interactions | ISO | PELO (Homo sapiens) | 6480464 | [NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of PELO mRNA | CTD | PMID:27188386 | Pelo | Rat | ethanol | increases expression | ISO | Pelo (Mus musculus) | 6480464 | Ethanol results in increased expression of PELO mRNA | CTD | PMID:30319688 | Pelo | Rat | ethyl methanesulfonate | decreases expression | ISO | PELO (Homo sapiens) | 6480464 | Ethyl Methanesulfonate results in decreased expression of PELO mRNA | CTD | PMID:24211769 | Pelo | Rat | etoposide | decreases expression | ISO | PELO (Homo sapiens) | 6480464 | Etoposide results in decreased expression of PELO mRNA | CTD | PMID:24211769 | Pelo | Rat | flutamide | increases expression | EXP | | 6480464 | Flutamide results in increased expression of PELO mRNA | CTD | PMID:24136188 | Pelo | Rat | folic acid | multiple interactions | ISO | Pelo (Mus musculus) | 6480464 | [1 and 2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of PELO mRNA | CTD | PMID:22206623 | Pelo | Rat | formaldehyde | decreases expression | ISO | PELO (Homo sapiens) | 6480464 | Formaldehyde results in decreased expression of PELO mRNA | CTD | PMID:20655997 | Pelo | Rat | FR900359 | increases phosphorylation | ISO | PELO (Homo sapiens) | 6480464 | FR900359 results in increased phosphorylation of PELO protein | CTD | PMID:37730182 | Pelo | Rat | hydroxyurea | decreases expression | ISO | PELO (Homo sapiens) | 6480464 | Hydroxyurea results in decreased expression of PELO mRNA | CTD | PMID:24211769 | Pelo | Rat | ivermectin | decreases expression | ISO | PELO (Homo sapiens) | 6480464 | Ivermectin results in decreased expression of PELO protein | CTD | PMID:32959892 | Pelo | Rat | lead(0) | affects expression | ISO | PELO (Homo sapiens) | 6480464 | Lead affects the expression of PELO mRNA | CTD | PMID:28903495 | Pelo | Rat | mercury dibromide | multiple interactions | ISO | PELO (Homo sapiens) | 6480464 | [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of PELO mRNA | CTD | PMID:27188386 | Pelo | Rat | methapyrilene | increases methylation | ISO | PELO (Homo sapiens) | 6480464 | Methapyrilene results in increased methylation of PELO exon | CTD | PMID:30157460 | Pelo | Rat | mitomycin C | decreases expression | ISO | PELO (Homo sapiens) | 6480464 | Mitomycin results in decreased expression of PELO mRNA | CTD | PMID:24211769 | Pelo | Rat | nefazodone | increases expression | EXP | | 6480464 | nefazodone results in increased expression of PELO mRNA | CTD | PMID:24136188 | Pelo | Rat | nickel atom | decreases expression | ISO | PELO (Homo sapiens) | 6480464 | Nickel results in decreased expression of PELO mRNA | CTD | PMID:25583101 | Pelo | Rat | nickel dichloride | affects expression | EXP | | 6480464 | nickel chloride affects the expression of PELO mRNA | CTD | PMID:22546817 | Pelo | Rat | nickel sulfate | decreases expression | ISO | PELO (Homo sapiens) | 6480464 | nickel sulfate results in decreased expression of PELO mRNA | CTD | PMID:22714537 | Pelo | Rat | nimesulide | increases expression | EXP | | 6480464 | nimesulide results in increased expression of PELO mRNA | CTD | PMID:24136188 | Pelo | Rat | oxaliplatin | multiple interactions | EXP | | 6480464 | [oxaliplatin co-treated with Topotecan] results in increased expression of PELO mRNA | CTD | PMID:25729387 | Pelo | Rat | p-chloromercuribenzoic acid | increases expression | ISO | PELO (Homo sapiens) | 6480464 | p-Chloromercuribenzoic Acid results in increased expression of PELO mRNA | CTD | PMID:26272509 | Pelo | Rat | p-chloromercuribenzoic acid | multiple interactions | ISO | PELO (Homo sapiens) | 6480464 | [NOG protein co-treated with p-Chloromercuribenzoic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of PELO mRNA | CTD | PMID:27188386 | Pelo | Rat | paracetamol | affects expression | ISO | Pelo (Mus musculus) | 6480464 | Acetaminophen affects the expression of PELO mRNA | CTD | PMID:17562736 | Pelo | Rat | pentachlorophenol | increases expression | ISO | Pelo (Mus musculus) | 6480464 | Pentachlorophenol results in increased expression of PELO mRNA | CTD | PMID:23892564 | Pelo | Rat | perfluorooctanoic acid | increases expression | EXP | | 6480464 | perfluorooctanoic acid results in increased expression of PELO mRNA | CTD | PMID:19162173 | Pelo | Rat | phenobarbital | increases expression | EXP | | 6480464 | Phenobarbital results in increased expression of PELO mRNA | CTD | PMID:19162173 | Pelo | Rat | phenobarbital | affects expression | ISO | PELO (Homo sapiens) | 6480464 | Phenobarbital affects the expression of PELO mRNA | CTD | PMID:19159669 | Pelo | Rat | phenylmercury acetate | increases expression | ISO | PELO (Homo sapiens) | 6480464 | Phenylmercuric Acetate results in increased expression of PELO mRNA | CTD | PMID:26272509 | Pelo | Rat | phenylmercury acetate | multiple interactions | ISO | PELO (Homo sapiens) | 6480464 | [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of PELO mRNA | CTD | PMID:27188386 | Pelo | Rat | progesterone | multiple interactions | ISO | PELO (Homo sapiens) | 6480464 | [Estradiol co-treated with Progesterone] results in increased expression of PELO mRNA | CTD | PMID:20660070 | Pelo | Rat | quercetin | decreases expression | ISO | PELO (Homo sapiens) | 6480464 | Quercetin results in decreased expression of PELO mRNA | CTD | PMID:21632981 | Pelo | Rat | SB 431542 | multiple interactions | ISO | PELO (Homo sapiens) | 6480464 | [NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1 more ... | CTD | PMID:27188386 | Pelo | Rat | sodium arsenite | increases expression | ISO | PELO (Homo sapiens) | 6480464 | sodium arsenite results in increased expression of PELO mRNA | CTD | PMID:38568856 | Pelo | Rat | sodium arsenite | decreases expression | ISO | PELO (Homo sapiens) | 6480464 | sodium arsenite results in decreased expression of PELO protein | CTD | PMID:30528433 | Pelo | Rat | sodium dichromate | increases expression | EXP | | 6480464 | sodium bichromate results in increased expression of PELO mRNA | CTD | PMID:25993096 | Pelo | Rat | tetrachloromethane | increases expression | EXP | | 6480464 | Carbon Tetrachloride results in increased expression of PELO mRNA | CTD | PMID:31150632 | Pelo | Rat | tetrachloromethane | increases expression | ISO | Pelo (Mus musculus) | 6480464 | Carbon Tetrachloride results in increased expression of PELO mRNA | CTD | PMID:31919559 | Pelo | Rat | tetrachloromethane | multiple interactions | EXP | | 6480464 | schizandrin B inhibits the reaction [Carbon Tetrachloride results in increased expression of PELO mRNA] | CTD | PMID:31150632 | Pelo | Rat | titanium dioxide | decreases expression | ISO | Pelo (Mus musculus) | 6480464 | titanium dioxide results in decreased expression of PELO mRNA | CTD | PMID:29264374 | Pelo | Rat | titanium dioxide | decreases methylation | ISO | Pelo (Mus musculus) | 6480464 | titanium dioxide results in decreased methylation of PELO gene | CTD | PMID:35295148 | Pelo | Rat | topotecan | multiple interactions | EXP | | 6480464 | [oxaliplatin co-treated with Topotecan] results in increased expression of PELO mRNA | CTD | PMID:25729387 | Pelo | Rat | trichostatin A | increases expression | ISO | PELO (Homo sapiens) | 6480464 | trichostatin A results in increased expression of PELO mRNA | CTD | PMID:24935251 | Pelo | Rat | urethane | increases expression | ISO | PELO (Homo sapiens) | 6480464 | Urethane results in increased expression of PELO mRNA | CTD | PMID:28818685 | Pelo | Rat | valdecoxib | increases expression | EXP | | 6480464 | valdecoxib results in increased expression of PELO mRNA | CTD | PMID:24136188 | Pelo | Rat | valproic acid | affects expression | ISO | Pelo (Mus musculus) | 6480464 | Valproic Acid affects the expression of PELO mRNA | CTD | PMID:17292431 | Pelo | Rat | valproic acid | multiple interactions | ISO | PELO (Homo sapiens) | 6480464 | [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of PELO mRNA | CTD | PMID:27188386 | Pelo | Rat | valproic acid | increases expression | ISO | PELO (Homo sapiens) | 6480464 | Valproic Acid results in increased expression of PELO mRNA | CTD | PMID:24383497 more ... | Pelo | Rat | vincaleukoblastine | affects response to substance | ISO | PELO (Homo sapiens) | 6480464 | PELO protein affects the susceptibility to Vinblastine | CTD | PMID:16217747 | Pelo | Rat | vorinostat | increases expression | ISO | PELO (Homo sapiens) | 6480464 | vorinostat results in increased expression of PELO mRNA | CTD | PMID:27188386 | |